rifampicin quinone

Rifampicin quinone is a chemical analog of rifampicin in which rifampicin’s structure is oxidized to a quinone form. It has been investigated primarily in preclinical studies as a molecule with lower antimicrobial activity than rifampicin but with notable potential in ameliorating glucose toxicity, lowering HbA1c, and improving insulin sensitivity in models of diabetes. Rifampicin quinone demonstrates reduced antibacterial activity compared to rifampicin, but shows the ability to lower advanced glycation end products and may reduce diabetes-associated complications such as nephropathy. The protective mechanism may relate to its anti-glycating properties; however, the precise molecular mechanism of action in mammalian systems, especially as it pertains to glycemic control or other metabolic effects, is not fully elucidated as of the latest reports.

Other names

rifampicin quinoneRIF-Q